Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor

Molecular Pharmacology

Volumn 51, Issue 3, 1997, Pages 357-362

  Roettger, B F ^a   Ghanekar, D ^a   Rao, R ^a   Toledo, C ^a   Yingling, J ^b   Pinon, D ^a   Miller, L J ^a,c  

^a MAYO GRADUATE SCHOOL   (United States)

^b GLAXOSMITHKLINE   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; DEVAZEPIDE; GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DESENSITIZATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENDOCYTOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; RAT; RECEPTOR BLOCKING; SECOND MESSENGER;

EID: 0030993594     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Huganir, R. L., and P. Greengard. Regulation of neurotransmitter receptor desensitization by protein phosphorylation. Neuron 5:555-567 (1990).
2. Lefkowitz, R. J., S. Cotecchia, M. A. Kjelsberg, J. Pitcher, W. J. Koch, J. Inglese, and M. G. Caron. Adrenergic receptors: Recent insights into their mechanism of activation and desensitization. Adv. Second Messenger Phosphoprotein Res. 28:1-9 (1993).
3. Meltzer, H. Y., and J. F. Nash. Effect of antipsychotic drugs on serotonin receptors. Pharmacol. Rev. 43:588-600 (1991).
4. Labrecque, J., A. Fargin, M. Bouvier, P. Chidiac, and M. Dennis. Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells. Mol. Pharmacol. 48:150-159 (1995).
5. 3H]-(±)-L-364,718: a new potent, nonpeptide cholecystokinin antagonist radioligand selective for peripheral receptors. Mol. Pharmacol. 30:212-217 (1986).
6. Toledo, C. F., B. F. Roettger, C. Morys-Wortmann, W. E. Schmidt, and L. J. Miller. Cellular handling of the unoccupied and agonist-stimulated cholecystokinin receptor determined by immunolocalization. Am. J. Physiol., in press.
7. Powers, S. P., D. I. Pinon, and L. J. Miller. Use of N,O-bis-Fmoc-D-Tyr-ONSu for introduction of an oxidative iodination site into cholecystokinin family peptides. Int. J. Pept. Protein Res. 31:429-434 (1988).
8. 33)CCK-26-33). J. Biol. Chem. 263:5295-5300 (1988).
9. Pearson, R. K., S. P. Powers, E. M. Hadac, H. Gaisano, and L. J. Miller. Establishment of a new short, protease-resistant, affinity labeling reagent for the cholecystokinin receptor. Biochem. Biophys. Res. Commun. 147: 346-353 (1987).
10. Hadac, E. M., D. Ghanekar, E. L. Holicky, D. I. Pinon, R. W. Dougherty, and L. J. Miller. Establishment and characterization of a cell line expressing a high affinity cholecystokinin receptor: role of glycosylation in agonist binding. Pancreas 13:130-139 (1996).
11. Munson, P. J., and D. Rodbard. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107:220-239 (1980).
12. Grynkiewicz, G., M. Poenie, and R. Y. Tsien. A new generation of calcium indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440-3450 (1985).
13. Holtmann, M. H., S. Ganguli, E. M. Hadac, V. Dolu, and L. J. Miller. Multiple extracellular loop domains contribute critical determinants for agonist binding and activation of the secretin receptor. J. Biol. Chem. 271:14944-14949 (1996).
14. McConnell, H. M., J. C. Owicki, J. W. Parce, D. L. Miller, G. T. Baxter, H. G. Wada, and S. Pitchford. The cytosensor microphysiometer: biological applications of silicon technology. Science (Washington D. C.) 257:1906-1912 (1992).
15. Roettger, B. F., R. U. Rentsch, D. Pinon, E. Holicky, E. Hadac, J. M. Larkin, and L. J. Miller. Dual pathways of internalization of the cholecystokinin receptor. J. Cell Biol. 128:1029-1042 (1995).
16. Klueppelberg, U. G., L. K. Gates, F. S. Gorelick, and L. J. Miller. Agonist-regulated phosphorylation of the pancreatic cholecystokinin receptor. J. Biol. Chem. 266:2403-2408 (1991).
17. Ozcelebi, F., R. V. Rao, E. Holicky, B. J. Madden, D. J. McCormick, and L. J. Miller. Phosphorylation of cholecystokinin receptors expressed on Chinese hamster ovary cells: similarities and differences relative to native pancreatic acinar cells. J. Biol. Chem. 271:3750-3755 (1996).
18. Nagain, C., M. C. Galas, M. F. Lignon, M. Rodriguez, J. Martinez, and C. Roze. Synthetic CCK8 analogs with antagonist activity on pancreatic receptors: in vivo study in the rat, compared to non-peptidic antagonists. Pancreas 6:275-281 (1991).
19. Marino, C. R., S. D. Leach, J. F. Schaefer, L. J. Miller, and F. S. Gorelick. Characterization of cAMP-dependent protein kinase activation by CCK in rat pancreas. FEBS Lett. 316:48-52 (1993).
20. 2-adrenergic receptor facilitate sequestration. Biochemistry 35:4155-4160 (1996).
21. Ferguson, S. S. G., W. E. Downey III, A. M. Colapietro, L. S. Barak, L. Ménard, and M. G. Caron. Role of β-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science (Washington D. C.) 271:363-366 (1996).
22. Heuser, J. E., and R. G. W. Anderson. Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J. Cell Biol. 108:389-400 (1989).